FI117376B - Hainrustouutteiden käyttö valmistettaessa lääkettä kollagenolyysi- tai tulehdustekijän sisältävän sairauden hoitamiseksi - Google Patents

Hainrustouutteiden käyttö valmistettaessa lääkettä kollagenolyysi- tai tulehdustekijän sisältävän sairauden hoitamiseksi Download PDF

Info

Publication number
FI117376B
FI117376B FI973195A FI973195A FI117376B FI 117376 B FI117376 B FI 117376B FI 973195 A FI973195 A FI 973195A FI 973195 A FI973195 A FI 973195A FI 117376 B FI117376 B FI 117376B
Authority
FI
Finland
Prior art keywords
cartilage
extract
use according
disease
molecular weight
Prior art date
Application number
FI973195A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI973195A0 (fi
FI973195A (fi
Inventor
Eric Dupont
Paul Brazeau
Christina Juneau
Daniel H Meas
Kenneth Marenus
Original Assignee
Aeterna Zentaris Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/384,555 external-priority patent/US5618925A/en
Application filed by Aeterna Zentaris Inc filed Critical Aeterna Zentaris Inc
Publication of FI973195A0 publication Critical patent/FI973195A0/fi
Publication of FI973195A publication Critical patent/FI973195A/fi
Application granted granted Critical
Publication of FI117376B publication Critical patent/FI117376B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
FI973195A 1995-02-03 1997-08-01 Hainrustouutteiden käyttö valmistettaessa lääkettä kollagenolyysi- tai tulehdustekijän sisältävän sairauden hoitamiseksi FI117376B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US38455595 1995-02-03
US08/384,555 US5618925A (en) 1994-04-28 1995-02-03 Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof
PCT/CA1995/000617 WO1996023512A1 (en) 1995-02-03 1995-10-30 Extracts of shark cartilage, process of production and uses thereof
CA9500617 1995-10-30

Publications (3)

Publication Number Publication Date
FI973195A0 FI973195A0 (fi) 1997-08-01
FI973195A FI973195A (fi) 1997-10-01
FI117376B true FI117376B (fi) 2006-09-29

Family

ID=23517788

Family Applications (1)

Application Number Title Priority Date Filing Date
FI973195A FI117376B (fi) 1995-02-03 1997-08-01 Hainrustouutteiden käyttö valmistettaessa lääkettä kollagenolyysi- tai tulehdustekijän sisältävän sairauden hoitamiseksi

Country Status (23)

Country Link
EP (1) EP0806960B1 (ja)
JP (3) JPH11502514A (ja)
KR (1) KR100347880B1 (ja)
CN (1) CN1138550C (ja)
AT (1) ATE230272T1 (ja)
AU (1) AU717978B2 (ja)
BG (1) BG63801B1 (ja)
BR (1) BR9510540A (ja)
CA (1) CA2212010C (ja)
CZ (1) CZ292627B6 (ja)
DE (1) DE69529300T2 (ja)
DK (1) DK0806960T3 (ja)
ES (1) ES2188672T3 (ja)
FI (1) FI117376B (ja)
HU (1) HU222088B1 (ja)
IS (1) IS1963B (ja)
MX (1) MX9705894A (ja)
NO (1) NO318950B1 (ja)
NZ (1) NZ294553A (ja)
PL (1) PL188137B1 (ja)
RO (1) RO117590B1 (ja)
RU (1) RU2157695C2 (ja)
WO (1) WO1996023512A1 (ja)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6380366B1 (en) 1994-04-28 2002-04-30 Les Laboratoires Aeterna Inc. Shark cartilage extract:process of making, methods of using and compositions thereof
US6025334A (en) * 1994-04-28 2000-02-15 Les Laboratoires Aeterna Inc. Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
AU724654B2 (en) * 1995-04-21 2000-09-28 Aeterna Zentaris Inc. Extracts of shark cartilage
AU6639898A (en) 1997-02-20 1998-09-09 Industrial Research Limited Angiogenesis inhibitors and activators from shark cartilage
DE69815310T2 (de) * 1997-03-11 2004-04-22 Les Laboratoires Aeterna Inc. Zubereitungen zur tumorbehandlung enthaltend hai-knorpelextrakte und antineoplastische mittel
KR100732322B1 (ko) * 1997-07-11 2007-06-25 에프엑스 라이프 싸이언스즈 인터내셔널 게엠베하 피에이취에프 과다 또는 세포내 칼슘 과다와 관련한질병을 치료하기 위한 상어 연골에서 유래한 조제물
AUPO920597A0 (en) * 1997-09-16 1997-10-09 Micronized Foods Pty Ltd Pharmaceutical and/or therapeutic composition or preparation comprising shark cartilage and emu oil
US20020009501A1 (en) * 1998-07-23 2002-01-24 Eric Dupont Preparation of cartilage extracts using organic solvents
US6168807B1 (en) 1998-07-23 2001-01-02 Les Laboratoires Aeterna Inc. Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof
CN1064690C (zh) * 1998-09-10 2001-04-18 中国人民解放军海军医学研究所 鲨鱼软骨血管生成抑制因子及其分离纯化方法
US6248341B1 (en) * 2000-01-14 2001-06-19 Color Access, Inc. Method of treating topical angiogenesis-related disorders
WO2001078674A1 (en) * 2000-04-18 2001-10-25 Ceteris Holding B.V. -Amsterdam (Olanda)- Succursale Di Lugano A composition based on natural extracts useful in the prevention and treatment of cutaneous wrinkles
JP2004516272A (ja) * 2000-12-20 2004-06-03 インダストリアル リサーチ リミテッド サメ肉抽出物
WO2004083257A1 (ja) * 2003-03-20 2004-09-30 Hosokawa Micron Corporation 軟骨魚類から単離されたプロテオグリカンおよびその製造方法
ES2223291B1 (es) * 2003-08-06 2006-03-16 Bioiberica, S.A. Nuevo uso terapeutico de condroitin sulfato.
US7205006B2 (en) * 2003-09-25 2007-04-17 Prime Pharmaceutical Corporation Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
CN100377741C (zh) * 2004-02-23 2008-04-02 江卫世 注射用复方骨肽及其制备工艺
US20070248930A1 (en) 2005-02-17 2007-10-25 Biolux Research Ltd. Light therapy apparatus and methods
WO2012075584A1 (en) 2010-12-08 2012-06-14 Biolux Research Limited Methods and apparatuses useful for regulating bone remodeling or tooth movement using light therapy, a functional appliance, and/or vitamin d
CN104244959B (zh) * 2011-12-04 2019-01-04 大卫·L·刘 一种由Na+和Ca2+组成的治疗癌症和肿瘤的注射药物
RU2489906C1 (ru) * 2012-04-18 2013-08-20 Тамара Ивановна Николаева Биологически активная добавка к пище на основе денатурированного коллагена
US20130287859A1 (en) * 2012-04-26 2013-10-31 Lescarden Inc. Method for treating prupritus with cartilage extract
DE102012023927A1 (de) * 2012-12-06 2014-06-12 Heinrich Huber Heilsalbe gegen Psoriasis, auch als Wundsalbe verwendbar; 50 ml ohne Konservierung
JP6484235B2 (ja) 2013-10-22 2019-03-13 バイオルックス リサーチ リミテッド 口腔内光治療装置及びその使用方法
CN106492065A (zh) * 2016-10-20 2017-03-15 王凯茜 一种治疗风湿热的中药
KR102369902B1 (ko) * 2021-04-23 2022-03-02 이수한 전 처리된 캐비아가 함유된 철갑상어 진액 및 그 제조 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4822607A (en) * 1976-10-29 1989-04-18 Lescarden Ltd. Anti-tumor agent and method
US4473551A (en) * 1982-08-23 1984-09-25 Faxon Pharmaceuticals, Inc. Anti-inflammatory composition
US5075112A (en) * 1990-02-12 1991-12-24 Cartilage Technologies Inc. Method of and dosage unit for inhibiting angiogenesis or vascularization in an animal using shark cartilage
US5618925A (en) * 1994-04-28 1997-04-08 Les Laboratories Aeterna Inc. Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof

Also Published As

Publication number Publication date
NZ294553A (en) 1999-07-29
JPH11502514A (ja) 1999-03-02
CZ292627B6 (cs) 2003-11-12
BR9510540A (pt) 1998-06-09
BG63801B1 (bg) 2003-01-31
CA2212010A1 (en) 1996-08-08
PL188137B1 (pl) 2004-12-31
CN1177927A (zh) 1998-04-01
CN1138550C (zh) 2004-02-18
HU222088B1 (hu) 2003-04-28
KR100347880B1 (ko) 2002-12-02
IS4537A (is) 1997-08-01
IS1963B (is) 2004-12-15
HUT77488A (hu) 1998-05-28
DE69529300D1 (de) 2003-02-06
FI973195A0 (fi) 1997-08-01
MX9705894A (es) 1998-07-31
BG101870A (en) 1998-04-30
JP2006290904A (ja) 2006-10-26
ES2188672T3 (es) 2003-07-01
RO117590B1 (ro) 2002-05-30
RU2157695C2 (ru) 2000-10-20
AU717978B2 (en) 2000-04-06
NO973564D0 (no) 1997-08-01
CZ245297A3 (cs) 1998-01-14
CA2212010C (en) 2004-08-17
JP2003246742A (ja) 2003-09-02
EP0806960B1 (en) 2003-01-02
DK0806960T3 (da) 2003-04-22
PL321678A1 (en) 1997-12-22
ATE230272T1 (de) 2003-01-15
EP0806960A1 (en) 1997-11-19
DE69529300T2 (de) 2003-07-03
FI973195A (fi) 1997-10-01
AU3738895A (en) 1996-08-21
WO1996023512A1 (en) 1996-08-08
NO973564L (no) 1997-10-01
NO318950B1 (no) 2005-05-30

Similar Documents

Publication Publication Date Title
FI117376B (fi) Hainrustouutteiden käyttö valmistettaessa lääkettä kollagenolyysi- tai tulehdustekijän sisältävän sairauden hoitamiseksi
US6025334A (en) Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
FI117375B (fi) Hainrustouutteet, joissa on antiangiogeenistä aktiivisuutta ja vaikutusta kasvaimen takautumiseen, sekä menetelmä mainittujen uutteiden valmistamiseksi
US6028118A (en) Methods of using extracts of shark cartilage
US6380366B1 (en) Shark cartilage extract:process of making, methods of using and compositions thereof
AU724654B2 (en) Extracts of shark cartilage
CA2299956A1 (en) Shark cartilage extract: process of making, methods of using and compositions thereof

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 117376

Country of ref document: FI

MA Patent expired